Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections

Richard Gale, Claire Gill, Maria Pikoula, AAron Lee, Rachel Hanson, Spiros Denaxus, Catherine Egan, Adnan Tufail, Paul Taylor

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections'. Together they form a unique fingerprint.

Medicine & Life Sciences